FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats
- FDA Seeks Public Input to Advance Development of Botanical Drug Products
- FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
- FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
- FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle
- FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
- FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
- FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
- FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
- FDA Issues Emergency Use Authorization for Drug to Prevent New World Screwworm in Multiple Species, Including Sheep, Cattle, Goats, and Swine
- FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
- FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
- FDA Licenses First-Ever Freeze-Dried Plasma Product in the U.S.